Company intelligence / Profile preview

Pulmuone

Seoul, South Korea

Ownership: Private
Employees: ~3700
Development stage: Other

Overview

Pulmuone is the number one global tofu brand, with food safety and innovation recognized in Korea, the US, Japan, and China. Clinical-grade results are not relevant because most products are foods and supplements, though R&D in cell-cultured seafood is underway with automation and robotics partners.

Therapeutic areas: GastroenterologyOtherImmunology
Modalities: Plant-based food productsProbiotics (nutraceutical/food supplement)NutraceuticalsCell-cultured seafood (cellular agriculture, protein)
Industry: Food & Nutrition

Partnerships

Danone (JV for yogurt)ABB Robotics (cell-cultured seafood automation)Walmart (retail/distribution in China)Sam's Club (retail/distribution in China)

Beyond the preview

Go deeper on Pulmuone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmuone.

Explore the full profile